A member asked:

I have cirrhosis & fatty liver disease been askd 2 do a study called placebo controlled trial evaluating the safety of gs-6624.should l try it or not?

3 doctors weighed in across 2 answers

Your decision: Research studies done that follow ethical guidelines have some safety guidelines however possible adverse effects must be discussed and participation benefits.

Answered 8/1/2014

3.8k views

Thank
Dr. Kristel Hunt answered

Specializes in Hepatology

Your decision: Simtuzumab has shown some promise in reversing fibrosis yet as far as I know, this is a phase 2 trial (meaning we really don't know whether it works and/or what the side effects are in people). you need to talk to your physicians and get the full risk/benefit analysis. best of luck deciding.

Answered 8/2/2014

3.8k views

Thank

Related Questions